Back to 
Royal Bank of Canada
Royal Bank of Canada
MCRB
5 quarters
Position history for Royal Bank of Canada's holdings in Seres Therapeutics, Inc.
Yes. Royal Bank of Canada holds 11 shares of MCRB (Seres Therapeutics) as of its Q2 2026 13F filing. It reduced the position by 96 shares (-89.7%) from Q1 2026. Royal Bank of Canada has held MCRB in every 13F on record since Q2 2025, 5 quarterly filings.
Current Value
$0
Current Shares
11
Total Value Change
-$77,000
Total Shares Change
-6,943
Quarter-by-Quarter History
Other major holders of MCRB: Vanguard Group Inc., FMR LLC, Susquehanna International Group, LLP